Visus Therapeutics Appoints World-Renowned Ophthalmologist, Eric D. Donnenfeld, M.D., to Board of Directors

by Business Wire • 2023/01/11 • 0 Comments

SEATTLE--(BUSINESS WIRE)-- #VisusTx--Visus Therapeutics Inc. today announced the appointment of Eric D. Donnenfeld, M.D., to the Company’s Board of Directors.

← Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses

NextGen Healthcare Client Eye Health America Invests in Optimizing Patient and Provider Experience →

Post navigation